These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 541381)

  • 1. Determination of sulfinpyrazone and two of its metabolites in human plasma and urine by gas chromatography and selective detection.
    Jakobsen P; Pedersen AK
    J Chromatogr; 1979 Jul; 163(3):259-69. PubMed ID: 541381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-performance liquid chromatographic determination of sulfinpyrazone and its metabolites in plasma.
    Kuo BS; Kaplan LA; Ritschel WA
    Arzneimittelforschung; 1984; 34(5):548-50. PubMed ID: 6540568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of sulfinpyrazone and four metabolites in plasma and urine by high pressure liquid chromatography.
    Lentjes EG; Tan Y; Van Ginneken CA
    Pharm Weekbl Sci; 1985 Dec; 7(6):252-9. PubMed ID: 4080510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The assay of fentanyl and its metabolites in plasma of patients using gas chromatography with alkali flame ionisation detection and gas chromatography-mass spectrometry.
    Van Rooy HH; Vermeulen MP; Bovill JG
    J Chromatogr; 1981 Apr; 223(1):85-93. PubMed ID: 7251778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatographic analysis of sulfinpyrazone and its metabolites in biological fluids.
    Bjornsson TD; Wolfram KM; Routledge PA; Shand DG
    J Chromatogr; 1980 Mar; 181(3-4):417-25. PubMed ID: 7391155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New metabolites of sulfinpyrazone in man.
    Dieterle W; Faigle JW; Moppert J
    Arzneimittelforschung; 1980; 30(6):989-93. PubMed ID: 7191279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gas chromatographic-mass fragmentographic determination of trazodone in rat plasma.
    Belvedere G; Frigerio A; Pantarotto C
    J Chromatogr; 1975 Oct; 112():631-6. PubMed ID: 1184692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two metabolites of sulphinpyrazone and their identification and determination by mass spectrometry.
    Jakobsen P; Pedersen AK
    J Pharm Pharmacol; 1981 Feb; 33(2):89-92. PubMed ID: 6111605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitive mass fragmentographic determination of acidic catecholamine metabolites in human body fluids.
    Jacob K; Vogt W; Schwertfeger G
    J Chromatogr; 1984 May; 290():331-7. PubMed ID: 6736166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of a new GLC-AFID method with a GLC-MS selected ion monitoring technique and a radioimmunoassay for the determination of plasma concentrations of imipramine and desipramine.
    Midha KK; Charette C; Cooper JK; McGilveray IJ
    J Anal Toxicol; 1980; 4(5):237-43. PubMed ID: 7442136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of sulphinpyrazone in patient plasma by gas chromatography.
    Rosenfeld J; Buchanan M; Powers P; Hirsh J; Barnett HJ; Stuart RK
    Thromb Res; 1978 Feb; 12(2):247-55. PubMed ID: 635842
    [No Abstract]   [Full Text] [Related]  

  • 12. Gas chromatographic-mass fragmentographic determination of propiverine and its metabolites in plasma and urine.
    Marunaka T; Umeno Y; Minami Y; Matsushima E; Maniwa M; Yoshida K; Nagamachi M
    J Chromatogr; 1987 Sep; 420(1):43-52. PubMed ID: 3667829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of sulfinpyrazone and four of its metabolites by high-performance liquid chromatography.
    Jakobsen P; Pedersen AK
    J Chromatogr; 1981 May; 223(2):460-5. PubMed ID: 7251803
    [No Abstract]   [Full Text] [Related]  

  • 14. Kinetics and metabolism of sulfinpyrazone.
    Mahony C; Wolfram KM; Nash PV; Bjornsson TD
    Clin Pharmacol Ther; 1983 Apr; 33(4):491-7. PubMed ID: 6831828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biotransformation and pharmacokinetics of sulfinpyrazone (Anturan) in man.
    Dieterle W; Faigle JW; Mory H; Richter WJ; Theobald W
    Eur J Clin Pharmacol; 1975 Dec; 9(2-3):135-45. PubMed ID: 786687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gas--liquid chromatographic determination of flurazepam and its major metabolites in plasma with electron-capture detection.
    Cooper SF; Drolet D
    J Chromatogr; 1982 Sep; 231(2):321-31. PubMed ID: 7130312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific and sensitive method for the determination of tobanum using gas chromatography with electron-capture and mass fragmentographic detection.
    Tomori E; Elekes I
    J Chromatogr; 1981 Jan; 204():355-60. PubMed ID: 6111567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative assay of sulphinpyrazone in plasma and urine by high-performance liquid chromatography.
    Lecaillon JB; Souppart C
    J Chromatogr; 1976 Jun; 121(2):227-34. PubMed ID: 932142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of sulfinpyrazone on the disposition of pseudoracemic phenprocoumon in humans.
    Heimark LD; Toon S; Gibaldi M; Trager WF; O'Reilly RA; Goulart DA
    Clin Pharmacol Ther; 1987 Sep; 42(3):312-9. PubMed ID: 3621786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of sulfinpyrazone and its metabolites in human serum and in solutions of human serum albumin.
    Jakobsen P; Pedersen AK; Andreasen F
    Acta Pharmacol Toxicol (Copenh); 1982 Sep; 51(3):243-9. PubMed ID: 7136730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.